Company
Healionics, Inc.
Healionics is developing safer, more reliable vascular access solutions to enhance the health and longevity of kidney failure patients while reducing the high cost of dialysis care.
Also known as Healionics
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Seattle
- Legal name
- Healionics
- healionics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Patients without functional kidneys need frequent blood filtration via dialysis to survive, but current methods to repeatedly access the bloodstream are risky, unreliable, and costly.
Funding snapshot
- Total raised
- $21.8MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Grant, $1.2M2024-05-10
Funding rounds
- Round, 2025
- $2M2025-12-16, SEC form D sold, 30 investors
- Grant
- $1.2M2024-05-10, Company stated
- Series A
- $5.5M2024-02-22, Company stated
- Round, 2023
- $5.5M2023-10-23, SEC form D sold, 70 investors
- Round, 2021
- $4.7M2021-05-13, Company stated
- Round, 2020
- $6.6M2020-12-04, SEC form D sold, 86 investors
- Round, 2019
- $4.5M2019-09-24, Company stated
- Round, 2018
- $4.2M2018-06-12, SEC form D sold, 72 investors
- Grant
- $1.7M2017-11-16, Company stated
- Grant
- $1.5M2015-12-01, Company stated
- Grant
- $1.3M2015-04-22, Company stated
- Round, 2013
- $50K2013-01-31, SEC form D sold, 1 investor
- Grant
- $900K2012-09-20, Company stated
- Round, 2011
- $196K2011-04-08, SEC form D sold, 7 investors
- Grant
- $244K2010-11-12, Company stated
- More rounds
- 1 earlier rounds recorded
Products
- Hardware
- STARgraft
Loading relationship preview